Latest News: Proscia Receives FDA 510(k) Clearance For Concentriq AP-DxREAD THE PRESS RELEASE

Proscia launches digital pathology software

Proscia
By Author Proscia | April 28, 2020

Artificial intelligence digital pathology software firm Proscia has made available its Concentriq Dx for reviewing and reporting on digital pathology slides in the United States. The software already has CE Mark for use in primary diagnosis in Europe. Its release comes as the U.S. Food and Drug Administration issued new guidance on April 27 to expand the availability of remote digital pathology tools and devices during the COVID-19 pandemic.

 

Our website uses cookies. By using this site, you agree to its use of cookies.